Hologic

Women's health imaging specialist. Dominant in mammography — Hologic shipped the first FDA-approved 3D tomosynthesis in 2011, defining the clinical standard.

Company history

• 1985 — founded as Diagnostic Health Services, later Hologic.
• 2006 — acquired R2 Technology (CAD).
• 2006 — acquired Suros Surgical Systems (breast biopsy).
• 2008 — acquired Third Wave Technologies (molecular diagnostics).
• 2011 — FDA PMA approval for Selenia Dimensions 3D tomosynthesis — first commercial tomo in the U.S.
• 2012 — acquired Gen-Probe (molecular diagnostics).

Product line by modality

• Mammography — Selenia (2D), Selenia Dimensions family (2D + 3D), 3Dimensions (current)
• Bone Densitometry — Horizon DXA family
• Breast biopsy — Affirm (stereotactic biopsy attachment on Dimensions / 3Dimensions)

Market position

Leader in mammography. Strong in bone densitometry. Not present in other imaging modalities — specialist positioning.